Exchange: OTC·Updated 09:44 AM EDT

VCNX Vaccinex Inc

$1.00
$0.00
(0.00%)
Today
Mkt Cap$2.68M
Vol320.00

About VCNX

Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the development of targeted bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The firm focuses on the development of Pepinemab for the treatment of non-small cell lung cancer, or NSCLC, osteosarcoma, melanoma, and Huntington’s disease. Its product pipeline includes the SEMA4D antibody platform and ActivMAb antibody discovery platform. The company was founded by Maurice Zauderer in1997 and is headquartered in Rochester, NY.
55

Bullish Sentiment

How do you feel about VCNX?

Advertisement|Remove ads.